Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer

BACKGROUND: Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) has achieved remarkable clinical efficacy in metastatic cancers such as melanoma and cervical cancer (CC). Here, we explored the safety, feasibility, and preliminary tumor response and performed translational investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, He, Nie, Cai-ping, Liu, Xiu-feng, Song, Bin, Yue, Jian-hui, Xu, Jing-xiao, He, Jia, Li, Kui, Feng, Yan-ling, Wan, Ting, Zheng, Min, Zhang, Yan-Na, Ye, Wei-Jun, Li, Jun-Dong, Li, Yan-Fang, Li, Jun-yun, Cao, Xin-Ping, Liu, Zhi-min, Zhang, Xiao-shi, Liu, Qing, Zhang, Xi, Liu, Ji-Hong, Li, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337833/
https://www.ncbi.nlm.nih.gov/pubmed/35727633
http://dx.doi.org/10.1172/JCI157726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337833/
https://www.ncbi.nlm.nih.gov/pubmed/35727633
http://dx.doi.org/10.1172/JCI157726

Ejemplares similares